Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Avax begins phase I/II study of L-Vax for treatment of AML

May 17, 2000

New treatments for ALL in active development at major research institute

May 16, 2000

BNP-7787 to enter phase III clinical trials as chemoprotectant

May 16, 2000

Lambda synthesizes photosensitizers with enhanced activity compared to Photofrin

May 16, 2000

Isolation, structure and biological activity of new Cdc25B tyrosine phosphatase inhibitors

May 12, 2000

Survival results promising in phase II study of 81C6 MAb in patients with recurrent brain tumors

May 12, 2000

PF-1201: new antitumor antibiotic selective for tumor gene-transformed cell lines

May 12, 2000

Kinase inhibitors under evaluation at major German pharmaceutical laboratory

May 11, 2000

Antitumor agents from American Cyanamid act by inhibiting PTKs

May 11, 2000

HMW endostatins for treatment and diagnosis of tumors disclosed by Haemopep

May 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...